What is Revvity's diagnostics — goodwill?

Revvity (RVTY) reported diagnostics — goodwill of $1.86B in Q1 2026.

How has Revvity's diagnostics — goodwill changed year-over-year?

Revvity's diagnostics — goodwill decreased by 4.0% year-over-year, from $1.94B to $1.86B.

What does diagnostics — goodwill mean?

Represents the intangible asset created when the diagnostics segment acquires another company for a price higher than the fair market value of its net identifiable assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property.

Revvity (RVTY) Diagnostics — Goodwill

Screener

Other segment segments

Life Sciences

$4.75B+3.9%

Similar metrics at other companies

DHRDiagnostics — Goodwill

$11.91B+70.8%

OPKDiagnostics — Goodwill

$163.44M0.0%

LHDiagnostics — Goodwill

$5.61B—

TMOSpecialty Diagnostics — Goodwill

$5.08B+6.1%

WAT

WATWaters Advanced Diagnostics — Goodwill

$3.37B—

TEC

TECHDiagnostics And Spatial Biology — Goodwill

$553.62M+1.1%

Other financials

Income statement

See full

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

See full

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

See full

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

See full

Market cap$12.83B+28.7%

Enterprise value$15.91B+28.6%

P/E53.5×+18.6×

P/S4.4×+0.9×

Profitability

See full

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

See full

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed: May 12, 2026, 4:07 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000031791-26-000019

Line item	Life Sciences	Diagnostics	Consolidated
Balance at December 28, 2025	$4,744,962	$1,868,531	$6,613,493
Foreign currency translation	(24,952)	(9,826)	(34,778)
Acquisitions	32,035	—	32,035
Balance at April 5, 2026	$4,752,045	$1,858,705	$6,610,750

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's diagnostics — goodwill?: Revvity (RVTY) reported diagnostics — goodwill of $1.86B in Q1 2026.
How has Revvity's diagnostics — goodwill changed year-over-year?: Revvity's diagnostics — goodwill decreased by 4.0% year-over-year, from $1.94B to $1.86B.
What does diagnostics — goodwill mean?: Represents the intangible asset created when the diagnostics segment acquires another company for a price higher than the fair market value of its net identifiable assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property.